Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports
Why it matters: Anthropic's acquisition of Coefficient Bio for $400M accelerates its expansion into the life sciences sector.
- Anthropic acquired Coefficient Bio for a reported $400 million in stock, according to The Information and Eric Newcomer.
- TechCrunch sources confirmed the deal's closure, though not the specific financial amount.
- Coefficient Bio was founded by Samuel Stanton and Nathan C. Frey, both previously from Genentech’s Prescient Design, to apply AI to drug discovery and biological research.
- Anthropic's health and life science team will integrate Coefficient Bio's approximately 10 employees.
- Claude for Life Sciences, a tool for scientific discovery, was previously announced by Anthropic in October, signaling their strategic focus on the sector.
AI giant Anthropic has acquired stealth biotech startup Coefficient Bio in a reported $400 million stock deal, a move confirmed by sources to TechCrunch and detailed by The Information and Eric Newcomer. This acquisition significantly bolsters Anthropic's push into healthcare and life sciences, integrating Coefficient Bio's AI-driven drug discovery expertise and its 10-person team into Anthropic's existing health initiatives.
